Mirion Technologies (NYSE:MIR – Get Free Report) had its price objective lowered by equities researchers at Robert W. Baird from $29.00 to $26.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of 44.96% from the stock’s current price.
MIR has been the topic of several other research reports. JPMorgan Chase & Co. decreased their target price on Mirion Technologies from $30.00 to $27.00 and set an “overweight” rating on the stock in a research report on Thursday. Melius Research raised Mirion Technologies to a “strong-buy” rating in a report on Monday, March 23rd. Citigroup reduced their price target on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. Morgan Stanley lowered their price objective on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 11th. Finally, The Goldman Sachs Group decreased their price target on shares of Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $27.25.
Get Our Latest Research Report on Mirion Technologies
Mirion Technologies Stock Performance
Mirion Technologies (NYSE:MIR – Get Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). The company had revenue of $277.40 million during the quarter, compared to analyst estimates of $281.17 million. Mirion Technologies had a net margin of 3.11% and a return on equity of 6.97%. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same quarter last year, the company posted $0.17 EPS. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. On average, sell-side analysts anticipate that Mirion Technologies will post 0.39 EPS for the current year.
Institutional Investors Weigh In On Mirion Technologies
Hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada raised its position in Mirion Technologies by 258.2% in the first quarter. Royal Bank of Canada now owns 98,828 shares of the company’s stock valued at $1,433,000 after purchasing an additional 71,241 shares during the last quarter. AQR Capital Management LLC raised its holdings in Mirion Technologies by 124.3% in the 1st quarter. AQR Capital Management LLC now owns 199,211 shares of the company’s stock valued at $2,889,000 after buying an additional 110,399 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Mirion Technologies by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 122,962 shares of the company’s stock worth $1,783,000 after buying an additional 5,366 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Mirion Technologies by 8.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 434,583 shares of the company’s stock worth $6,301,000 after acquiring an additional 34,973 shares during the last quarter. Finally, Cetera Investment Advisers bought a new stake in Mirion Technologies during the 2nd quarter worth approximately $288,000. 78.51% of the stock is currently owned by institutional investors and hedge funds.
About Mirion Technologies
Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
Read More
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
